Pharma’s post-pandemic launch performance problem: what’s the prognosis?
pharmaphorum
JUNE 29, 2022
Lockdowns are no longer; but the more hybrid model of physician and patient engagement is here to stay; the challenge for launching companies is how to optimise engagement impact and patient opportunity within them. She has been vice resident, European Marketing and Thought Leadership in IQVIA for 12 years. appeared first on.
59 
Let's personalize your content